Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andrew Jack is active.

Publication


Featured researches published by Andrew Jack.


BMJ | 2008

Balancing Big Pharma's books

Andrew Jack

With patents running out on their big earning products and recent scandals undermining their image, drug companies are under pressure. Andrew Jack reports on their problems


BMJ | 2011

Letting the sunshine in on doctor-pharma relationships

Andrew Jack

Drug companies are increasingly obliged to publish details of payments to doctors. The United States is leading the charge, but are we getting the full story in Europe? Andrew Jack reports


BMJ | 2014

Which way now for the Cancer Drugs Fund

Andrew Jack

The government has extended the Cancer Drugs Fund for a further two years and increased its budget. Andrew Jack explains how it works and why it is controversial


BMJ | 2015

Why the panic? South Korea’s MERS response questioned

Andrew Jack

Andrew Jack reports from Seoul on how government secrecy, poor infection control, and a lack of preparedness allowed the latest MERS outbreak to spark panic in South Korea


BMJ | 2014

Tamiflu: “a nice little earner”

Andrew Jack

Is the story of oseltamivir, and similar antiviral drugs, a classic one of big pharma greed? Andrew Jack finds a more nuanced reality


BMJ | 2009

Flu’s unexpected bonus

Andrew Jack

With over 96 countries stockpiling oseltamivir, Andrew Jack assesses who has benefited from pandemic flu


BMJ | 2015

Pfizer steps up battle to defend control of pregabalin

Andrew Jack

Pfizer’s actions over its biggest blockbuster drug sparks confusion


BMJ | 2009

The problem with flu vaccines

Andrew Jack

With the number of cases of swine flu continuing to rise, Andrew Jack assesses our capability to produce enough vaccine to cope with a pandemic


BMJ | 2016

Can anyone stop the illegal sale of medicines online

Andrew Jack; firstFT

Demand for and supply of unlicensed drugs online continues to grow despite regulators’ constant attempts to crack down on illegal activity, Andrew Jack reports


BMJ | 2014

US drug firm Pfizer seeks to buy UK company AstraZeneca

Andrew Jack

Pfizer, the US pharmaceutical giant whose drugs include atorvastatin (Lipitor) and sildenafil (Viagra), is seeking to buy the UK drug firm AstraZeneca for £52bn (€63bn;

Collaboration


Dive into the Andrew Jack's collaboration.

Researchain Logo
Decentralizing Knowledge